Delivery Order SPE2DB20D2002-SPE2DB23FL43M
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,551.55, is for the delivery of Novolog 100 Unit/mL Flexpen 3mL, a type of insulin delivery device. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award, valued at $1,529.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin product. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award, valued at $2,982.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of NovoLog 100 Unit/mL Flexpen 3mL, a prescription insulin product, with an ultimate completion date of April 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NovoLog 100 Unit/mL FlexPen 3mL medication. The $6,082.98 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company. The contract, valued at $1,134.80, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,676.32 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance extending through May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NovologTM 100 unit/mL Flexpen 3mL insulin products. The $1,703.48 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 28, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,088.58 firm fixed-price delivery order is for the supply of NovologTM 100 unit/mL FlexPen 3mL insulin pens. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.78 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a performance period through March 2025 and is a firm fixed-price agreement. There is no set-aside designation indicated for this award. Amerisourcebergen holds a significant...
- This federal contract award, valued at $2,255.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin product. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL43MDelivery Order
This federal contract award, valued at $1,622.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NovoLog 100 unit/mL FlexPen 3mL, a type of insulin medication. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/5/23 |